News Center

位置：

Honors Announcement

Group News

Media Reports

Shijiazhuang Sihua Pharmaceutical Selected for the Provincial List of Leading Enterprises to Be Cultivated in the Initiative to Build a Province Strong in Quality

Category:

Honors Announcement

发布时间：2025-01-02

【概要描述】 Recently, the Office of the Leading Group for the Quality-Driven Province Strategy of Hebei Province released the list of leading enterprises to be cultivated in the province’s quality-driven development initiative, and Shijiazhuang Sihua Pharmaceutical Co., Ltd. was successfully included.

Shijiazhuang Sihua Pharmaceutical Selected for the Provincial List of Leading Enterprises to Be Cultivated in the Initiative to Build a Province Strong in Quality

Recently, the Office of the Leading Group for the Quality-Driven Province Strategy of Hebei Province released the list of leading enterprises to be cultivated in the province’s quality-driven development initiative, and Shijiazhuang Sihua Pharmaceutical Co., Ltd. was successfully included.

According to available information, leading enterprises in the initiative to build a province strong in quality are selected based on a comprehensive assessment of their performance in areas such as quality management, development of quality infrastructure, preparation and submission for quality awards, formulation and revision of standards, brand value, collaborative innovation across the industrial chain, supplier management, and digital and intelligent transformation. These enterprises not only possess distinctive features and competitive advantages in their own development but also serve as industry leaders.

To better leverage the leading and exemplary role of quality benchmarks, drive quality transformation and innovation across industrial and supply chains, and elevate regional quality competitiveness, in accordance with the spirit of the General Office of the State Administration for Market Regulation’s “Notice on Launching the Cultivation of Leading Enterprises for Building a Quality-Oriented Nation” and the relevant deployment requirements of the National On-Site Promotion Conference on Sharing Best Practices in Building Quality-Oriented Enterprises, our province, based on recommendations from various cities, has identified 127 enterprises with solid quality management foundations and strong quality competitiveness to be included in the provincial list of leading enterprises for cultivating quality-oriented provinces.

In recent years, Shijiazhuang No. 4 Pharmaceutical has taken the promotion of high-quality enterprise development as its overarching theme and the enhancement of supply quality as its primary focus. By thoroughly implementing the strategies of building strong enterprises through quality and building strong provinces through quality, the company has significantly strengthened its overall capabilities in quality and branding, with increasingly pronounced quality advantages in both its products and geographic markets. As a result, the company has successively been recognized as a provincial benchmark for industrial enterprise quality and a national benchmark for quality.

“Being included on the provincial list for cultivating leading enterprises in the initiative to build a province strong in quality is a full recognition and affirmation of our company’s quality management and high-quality development,” said a relevant official from the Group. “We will steadfastly uphold our original aspiration of ‘producing high-quality medicines for the people,’ fully assume our role as the primary entity responsible for quality, and, in accordance with the Guidelines for Cultivating Leading Enterprises in the Initiative to Build a Province Strong in Quality, rigorously carry out quality-improvement initiatives, actively promote advanced quality-management methodologies, implement benchmarking, and continuously conduct research and development to drive quality-related technological innovation around our products and processes. In doing so, we will continually enhance our ‘three leaderships’—leading in product quality, setting the standard, and pioneering in patent innovation—thereby helping our enterprise achieve higher quality and greater efficiency, accelerating the improvement of our quality-management capabilities and competitive edge, and consistently strengthening the Stone Four Pharmaceutical brand.”

Keywords:

Shijiazhuang Sihua Pharmaceutical Group’s Sodium Acetate Ringer’s Glucose Injection Has Been Approved and Is Deemed to Have Passed the Consistency Evaluation.

Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Receives Approval for Nicethamide API

Shijiazhuang Sihua Pharmaceutical Group’s Sodium Acetate Ringer’s Glucose Injection Has Been Approved and Is Deemed to Have Passed the Consistency Evaluation.

Guangxiang Pharmaceutical of Shijiazhuang Sihua Pharmaceutical Group Receives Approval for Nicethamide API